A Longitudinal Study to Identify Mechanisms of Menopause on Cardiovascular Disease Risk
Launched by UNIVERSITY OF COPENHAGEN · Dec 3, 2022
Trial Information
Current as of February 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how menopause affects women's heart health over time. After menopause, the body stops producing estrogen, which can lead to a higher risk of heart problems such as hardening of the arteries, heart attacks, and strokes. The researchers will follow 200 women from before they enter menopause and for at least 10 years afterward. They will look closely at changes in the blood vessels, heart, and brain, and analyze blood samples to understand better how menopause influences cardiovascular health.
To be eligible for this study, women should have a normal heart test and regular menstrual cycles. However, there are some exclusions, such as those who smoke, are on hormone therapy, have certain chronic diseases, or are pregnant or breastfeeding. Participants can expect regular check-ups and tests to monitor their health throughout the study. This research aims to provide valuable insights into the connection between menopause and heart disease, which could help improve health strategies for women as they age.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Normal ECG
- • Regular menstruation
- Exclusion Criteria:
- • Participation in other clinical projects
- • Smokes or has smoked within the last 10 years
- • On hormone therapy
- • Has chronic diseases that are not expected, cf. the groups sought. Including heart problems, atrial fibrillation, cancer, immune diseases and previous strokes with functionally significant sequelae
- • Being treated with oral steroids
- • Has alcohol / drug abuse or is being treated with disulfiram (Antabus)
- • Is unable to understand the contents of the document with informed consent or the experimental procedures
- • Pregnancy or breastfeeding
- • Systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg
- • ovariectomy
- • BMI\>28
Trial Officials
Lasse Gliemann, PhD
Principal Investigator
Department of Nutrition, Exercise and Sports, University of Copenhagen, 2200 Copenhagen, Denmark
About University Of Copenhagen
The University of Copenhagen, a leading research institution in Denmark, is dedicated to advancing medical knowledge and improving patient outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its expertise in various fields, including health sciences, pharmacology, and biotechnology, to design and conduct rigorous clinical studies. Committed to ethical standards and scientific integrity, the University of Copenhagen aims to contribute significantly to the global medical community by facilitating groundbreaking research that addresses pressing healthcare challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Copenhagen, , Denmark
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials